Europe Allogeneic Human Chondrocyte Market to Surpass US$ 3,440.5 Million by 2027, Says Coherent Market Insights (CMI)

SEATTLE--(BUSINESS WIRE)--According to Coherent Market Insights, the Europe allogeneic human chondrocyte market is expected to be valued at US$ 3,440.5 million in 2027 and is expected to exhibit a CAGR of 10.2 % during the forecast period (2020-2027).

Key Trends and Analysis:

Key trends in the Europe allogeneic human chondrocyte market are increasing prevalence of osteoarthritis and musculoskeletal system disorders. This factor is expected to aid in growth of the market.

According to the State of Musculoskeletal Health, 2019, around 18.8 million people in the U.K. were suffering from a musculoskeletal condition in 2017. According to the same source, around 500,000 fractures occur every year due to osteoporosis in the U.K. Thus, such factors are contributing to growth of the Europe allogeneic human chondrocytes market.

Similarly, according to article in Acta Orthopaedica, the prevalence of osteoarthritis increased by 45% in Nordic countries in the span of 1990 to 2015.

Furthermore, adoption of various expansion strategies by key players is expected to propel the market growth during the forecast period. For instance, in June 2016, Thompson Street Capital Partners (TSCP), a private equity firm, announced the acquisition of commercial operations of ISTO Technologies, Inc., in order to support ISTO Technologies, Inc., by investing in sales force expansion, product development, and to increase the company’s reach within the spine and orthopedics markets.

Request for Sample copy @ https://www.coherentmarketinsights.com/insight/request-sample/4088

Key Market Takeaways:

The Europe allogeneic human chondrocyte market is expected to exhibit a CAGR of 10.2% during the forecast period, owing to increasing prevalence of musculoskeletal diseases. According to the data published by the Ministry of Health of Ukraine, the number of rheumatoid arthritis patients was around 116,492 (including over 49,420 people of working age).

Among country, Germany is expected to hold dominant position in the market during the forecast period, owing to increasing prevalence of osteoarthritis. According to an article published in the Journal of Health Monitoring in 2017, the Robert Koch Institute conducted a health interview survey during 2014 to 2015, which reported that approximately 17.9% of adults were suffering from osteoarthritis in Germany.

Competitive Landscape:

Key players operating in the Europe allogeneic human chondrocyte market include Kolon TissueGene, Inc. and ISTO Technologies Inc.

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4088

Market Segmentation:

• Europe Allogeneic Human Chondrocyte Market, By Application:
  • Osteoarthritis
  • Musculoskeletal System Disorders
  • Others
• Europe Allogeneic Human Chondrocyte Market, By End User:
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
• Europe Allogeneic Human Chondrocyte Market, By Country:
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Related Market Intelligence Report:

Epigenetics Drugs & Diagnostic Technologies Market, By Type (Epigenetic Drugs (DNMT Inhibitors (Azacitidine, Decitabine), HDAC Inhibitors (Vorinostat, Romidepsin)), Epigenetics Diagnostic Technologies (DNA Methylation, ChIP Technology)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Read more: https://www.coherentmarketinsights.com/market-insight/epigenetics-drugs-and-diagnostic-technologies-market-4026

Transcriptomics Technologies Market, By Technology (Microarrays, PCR, Gene Regulation Technologies, Next Generation Sequencing), By Application (Clinical Diagnostics, Drug Discovery & Research, Bioinformatics, Comparative Transcriptomics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027

Read more: https://www.coherentmarketinsights.com/market-insight/transcriptomics-technologies-market-3989

Cord Blood Banking Services Market, By Type (Public Cord Blood Banking Services, Private Cord Blood Banking Services), By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027

Read more: https://www.coherentmarketinsights.com/market-insight/cord-blood-banking-services-market-3913

Regenerative Therapies Market, By Tissue Type (Allograft, Xenograft, Alloplast), By Application (Soft Tissue Repair, Cardiovascular, Dental, Orthopedic, CNS disease treatment, Others), By End User (Hospitals, Ambulatory Surgical Centers, Educational Institutes), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 – 2027

Read more: https://www.coherentmarketinsights.com/market-insight/regenerative-therapies-market-3712

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide.